
Vector Vitale: Innovating therapeutic solutions for biomolecule symmetry correction.
Vector Vitale is dedicated to innovating therapeutic solutions aimed at correcting the symmetry of biomolecules such as amino acids, polypeptides, and proteins. Their products are designed to be re-dosed for sustainable effects, addressing critical needs in the biotechnology and pharmaceutical markets. The company boasts a team of specialists with expertise in physics, chemistry, technology, and life sciences, ensuring a multidisciplinary approach to their groundbreaking work.
Vector Vitale has made significant strides in the field of biomolecular therapy, leveraging extensive research in mathematical models of hierarchical stable systems. Their innovative solutions have the potential to revolutionize treatments by providing more effective and sustainable therapeutic options. The company's impact is underscored by its commitment to scientific excellence and its ability to attract top talent from various scientific disciplines.

Vymedic
vymedic.com

VectorBuilder
vectorbuilder.com

Vector Laboratories
vectorlabs.com

Vita Therapeutics

Vector Biomed
vectorbiomed.com

Faze Medicines
fazemed.com

Symic Biomedical

Vivita Technologies

Entrinsic Bioscience

Vitasol

VintaBio
vintabio.com

Health Vector
healthvector.world

nVector
nvector.com

Vibe Bio
vibebio.com

Variant Bio
variantbio.com
Companies similar to Vector Vitale include Vymedic, VectorBuilder, Vector Laboratories and Vita Therapeutics.
Vector Vitale was founded in 2015.
Vector Vitale's headquarters is located in North Miami Beach, FL, US.
Vector Vitale's most recent funding round was for $775.6k (USD) in January 2017.
As of Jan 17, 2017, Vector Vitale has raised a total of $775.6k (USD).
Vector Vitale has 30 employees as of Feb 5, 2024.